Abstract:Objective: To investigate the efficacy of surgical treatment for cutaneous malignant melanoma. Methods: Retrospective analysis of clinical records, surgical procedures and the prognosis was performed in 93 patients who were diagnosed of cutaneous malignant melanoma and underwent surgical treatment between October 2007 and December 2011. According to American Joint Committee on Cancer (AJCC) staging system, one patient was in stage ⅠA, two patients were in stage ⅠB, eight patients were in stage ⅡA, nine patients were in stage ⅡB, twenty patients were in stage ⅡC, eighteen patients were in stage ⅢA, seventeen patients were in stage ⅢB, sixteen patients were in stage ⅢC, and two patients were in stage Ⅳ. The surgical procedures include extensive skin resection for 26 patients, extensive skin resection plus construction with skin graft or local flap for 7 patients, finger (toe) amputation for 8 patients, ilioinguinal lymph node dissection for 32 patients, axillary lymph node dissection for 3 patients, extensive skin resection plus one-stage ilioinguinal lymph node dissection for 15 patients, and extensive skin resection plus one-stage axillary lymph node dissection for 2 patients. Fifty-three patients received adjuvant chemotherapy and seventy-eight patients received interferon or interleukin treatment. Of 93 patients, 77 patients were followed-up, with an average follow-up period of 20 months (range: 2-50 months). Results: All of three stage Ⅰ patients survived; of 28 stage Ⅱ patients, 8, 2 and 6 patients had linguinal lymph node, bone or skin metastasis 12, 18 and 36 months after surgical treatment, respectively; of 44 stage Ⅲ patients, 11 patients died of lung metastasis, and 5 patients died of liver metastasis during the follow-up; of 2 stage Ⅳ patients, 1 patients died of lung metastasis 12 months after surgical treatment, and 1 patient died of liver metastasis 11 months after surgical treatment. Of the 77 patients who were followed-up, 43 patients survived with neither local recurrence nor progressive disease. Conclusion: Early diagnosis and surgical treatment of cutaneous malignant melanoma can achieve desirable disease control, and the standardized regional lymph node dissection is important in the control of tumor progression, as well as the adjuvant therapy is benefit for the survival. DOI:10.3781/j.issn.1000-7431.2012.09.013

Surgical Treatment on Skin Benign and Malignant Tumor

Surgical management of facial malignant tumors

[Surgical Treatment of Scalp Malignant Tumor].

Surgical Treatment for Cutaneous Malignant Melanoma

Diagnosis and treatment of common malignant skin tumor

Clinical Research on Treatments Including Radiotherapy,chemotherapy,radical Surgery to Remove the Tumor,and Flap for Tissue Defect Repair for the Trunk Superficial Malignant Tumor

Surgical Treatment of Scrotum Paget Disease

Surgical repair and reconstruction of giant tumors of the scalp

[Surgical Treatment of Hemangioma and Vascular Malformation in Body Surface].

Surgical Therapy of Capillary Malformation in Head,Face and Neck

Highlights in diagnosis and surgical treatment of eyelid malignant tumors

Clinical Experience of the Treatment of Giant Congenital Benign Tumours of the Back

Case report repairing orbital skin defects using composite flaps after giant eyelid-derived tumor excision and orbital exenteration.

Surgical repair and treatment of recurrent dermatofibrosarcoma Protuberan

Surgical Repair and Cosmetic Evaluation of Basal Cell Cancer on Faces

Treatment of benign skin tumor and scar by fractional resection

Precise Resection and Defect Repair of External Nose Malignant Tumor

The Surgical Treatment of Malignant Tracheal Tumor

Desection and Reconstruction of Skin Cancer in Maxillofacial Region

Temprorarily Covered by Heterogeneous Skin Can Increase the Surgical Accuracy in Superficial Malignant Tumor Resection During Special Circumstances

Study on Cases of Nasal Tumors Treated by Dermatologic Surgery: Analysis of 63 Cases